Filtros de búsqueda

Lista de obras de Michael Boe Møller

A child with mastocytosis and lymphomatoid papulosis

artículo científico publicado en 2016

A clinically based prognostic index for diffuse large B-cell lymphoma with a cut-off at 70 years of age significantly improves prognostic stratification: population-based analysis from the Danish Lymphoma Registry

artículo científico publicado en 2015

A5.27 Ro52 Expression is a Prognostic Factor for Survival in B Cell Lymphoma

AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell Lymphoma.

artículo científico publicado en 2017

Aberrations of the p53 pathway components p53, MDM2 and CDKN2A appear independent in diffuse large B cell lymphoma.

artículo científico publicado en 1999

Addition of rituximab to chemotherapy overcomes the negative prognostic impact of cyclin E expression in diffuse large B-cell lymphoma

artículo científico publicado en 2013

Adult-onset systemic mastocytosis in monozygotic twins with KIT D816V and JAK2 V617F mutations.

artículo científico publicado en 2012

Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma--is it necessary?

artículo científico publicado en 2015

Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents

artículo científico publicado en 2020

Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma

artículo científico publicado en 2016

Association of testicular non-Hodgkin's lymphomas with elevated serum levels of human chorionic gonadotropin-like material

scientific article published on 01 March 1996

Bone marrow histomorphology and JAK2 mutation status in essential thrombocythemia

artículo científico publicado en 2007

CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

artículo científico publicado en 2013

Circulating KIT D816V mutation-positive non-mast cells in peripheral blood are characteristic of indolent systemic mastocytosis.

artículo científico publicado en 2012

Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma.

artículo científico publicado en 2018

Clinical and Biologic Significance of MYC Genetic Mutations in De Novo Diffuse Large B-cell Lymphoma

artículo científico publicado en 2016

Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries.

artículo científico publicado en 2015

Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.

artículo científico publicado en 2015

Clinical implications of phosphorylated STAT3 expression in De Novo diffuse large B-cell lymphoma

artículo científico publicado en 2014

Clinical relevance of sensitive and quantitative STAT3 mutation analysis using next-generation sequencing in T-cell large granular lymphocytic leukemia.

artículo científico publicado en 2014

Clinical significance of cyclin-dependent kinase inhibitor p27Kip1 expression and proliferation in non-Hodgkin's lymphoma: independent prognostic value of p27Kip1

artículo científico publicado en 1999

Clinicopathological features of plasmablastic multiple myeloma: a population-based cohort

artículo científico publicado en 2015

Comparison of gDNA-based versus mRNA-based KIT D816V mutation analysis reveals large differences between blood and bone marrow in systemic mastocytosis.

artículo científico publicado en 2016

Comparison of synthetic small-calibre biodegradable vs. stable ePTFE vascular prosthesis after long-term implantation in the rat aorta

scholarly article by Beat H. Walpoth et al published May 2013 in Cardiovascular Pathology

Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapy.

artículo científico publicado en 2017

Conditional survival of patients with diffuse large B-cell lymphoma.

artículo científico publicado en 2006

Cyclin D3 Expression in Non-Hodgkin Lymphoma

DNMT1 is predictive of survival and associated with Ki-67 expression in R-CHOP-treated diffuse large B-cell lymphomas

artículo científico publicado en 2017

DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study.

artículo científico publicado en 2017

Degradation and healing characteristics of small-diameter poly(epsilon-caprolactone) vascular grafts in the rat systemic arterial circulation

artículo científico publicado en 2008

Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms

artículo científico publicado en 2022

Development and blind clinical validation of a microRNA based predictor of response to treatment with R-CHO(E)P in DLBCL

artículo científico publicado en 2015

Differential protein expression of peroxiredoxin-1 in classical Hodgkin Lymphoma: a possible correlation to clinical behaviour

article

Diffuse large B-cell lymphoma classification system that associates normal B-cell subset phenotypes with prognosis

artículo científico publicado en 2015

Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation--a population-based study of 1575 cases

artículo científico publicado en 2004

Disrupted p53 function as predictor of treatment failure and poor prognosis in B- and T-cell non-Hodgkin's lymphoma

artículo científico publicado en 1999

Dual time-point FDG PET/CT and FDG uptake and related enzymes in lymphadenopathies: preliminary results

artículo científico publicado en 2016

Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma

artículo científico publicado en 2015

Effect of implantation site on outcome of tissue-engineered vascular grafts

artículo científico publicado en 2019

Epidemiology of systemic mastocytosis in Denmark.

artículo científico publicado en 2014

Erratum: Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries.

artículo científico publicado en 2015

Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions

artículo científico publicado en 2015

Evaluation of clinical trial eligibility and prognostic indices in a population-based cohort of systemic peripheral T-cell lymphomas from the Danish Lymphoma Registry

artículo científico publicado en 2014

Expression of osteoblast and osteoclast regulatory genes in the bone marrow microenvironment in multiple myeloma: only up-regulation of Wnt inhibitors SFRP3 and DKK1 is associated with lytic bone disease.

artículo científico publicado en 2013

Extreme neutrophil granulocytosis in a patient with anaplastic large cell lymphoma of T-cell lineage.

artículo científico publicado en 2007

FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas.

artículo científico publicado en 2015

FOXP2-positive diffuse large B-cell lymphomas exhibit a poor response to R-CHOP therapy and distinct biological signatures.

artículo científico publicado en 2016

Factors predicting long-term survival in low-risk diffuse large B-cell lymphoma

artículo científico publicado en 2003

Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma.

artículo científico publicado en 2002

Frequent disruption of the RB1 pathway in diffuse large B cell lymphoma: prognostic significance of E2F-1 and p16INK4A.

artículo científico publicado en 2000

HLA Associations and Risk of Posttransplant Lymphoproliferative Disorder in a Danish Population-Based Cohort

artículo científico publicado en 2015

Hepatitis C virus positive diffuse large B-cell lymphomas have distinct molecular features and lack BCL2 translocations

artículo científico publicado en 2017

Hepatocyte growth factor pathway upregulation in the bone marrow microenvironment in multiple myeloma is associated with lytic bone disease.

artículo científico publicado en 2013

High expression of PI3K core complex genes is associated with poor prognosis in chronic lymphocytic leukemia

artículo científico publicado en 2015

High intratumoral macrophage content is an adverse prognostic feature in anaplastic large cell lymphoma

artículo científico publicado en 2014

High levels of nuclear MYC protein predict the presence of MYC rearrangement in diffuse large B-cell lymphoma

artículo científico publicado en 2012

High prevalence of arterial thrombosis in JAK2 mutated essential thrombocythaemia: independence of the V617F allele burden

artículo científico publicado en 2008

Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL

scientific article published on 11 February 2019

Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone

artículo científico publicado en 2012

Improved detection of the KIT D816V mutation in patients with systemic mastocytosis using a quantitative and highly sensitive real-time qPCR assay

artículo científico publicado en 2011

Infantile hemophagocytic lymphohistiocytosis in a case of chediak-higashi syndrome caused by a mutation in the LYST/CHS1 gene presenting with delayed umbilical cord detachment and diarrhea

artículo científico publicado en 2015

KIT D816V mutation burden does not correlate to clinical manifestations of indolent systemic mastocytosis

artículo científico publicado en 2013

KIT D816V mutation-positive cell fractions in lesional skin biopsies from adults with systemic mastocytosis

artículo científico publicado en 2013

LPL gene expression is associated with poor prognosis in CLL and closely related to NOTCH1 mutations

artículo científico publicado en 2015

Limited efficacy of hydroxyurea in lowering of the JAK2 V617F allele burden

artículo científico publicado en 2009

Long term molecular responses in a cohort of Danish patients with essential thrombocythemia, polycythemia vera and myelofibrosis treated with recombinant interferon alpha

artículo científico publicado en 2013

Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma

artículo científico publicado en 2016

Low HIP1R mRNA and protein expression are associated with worse survival in diffuse large B-cell lymphoma patients treated with R-CHOP.

artículo científico publicado en 2015

MDM2 phenotypic and genotypic profiling, respective to TP53 genetic status, in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.

artículo científico publicado en 2013

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Pr

artículo científico publicado en 2013

Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation

artículo científico publicado en 1999

Mantle cell lymphoma: prognostic capacity of the Follicular Lymphoma International Prognostic Index.

artículo científico publicado en 2006

Microarray-based classification of diffuse large B-cell lymphoma

artículo científico publicado en 2005

Minimal residual disease and normalization of the bone marrow after long-term treatment with alpha-interferon2b in polycythemia vera. A report on molecular response patterns in seven patients in sustained complete hematological remission

article

Molecular control of the cell cycle in cancer: biological and clinical aspects.

artículo científico publicado en 2003

Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with rearrangements

artículo científico publicado en 2018

Multidisciplinary Management of Mastocytosis: Nordic Expert Group Consensus

artículo científico publicado en 2015

Multiplex polymerase chain reaction-based prognostic models in diffuse large B-cell lymphoma patients treated with R-CHOP.

artículo científico publicado en 2016

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

artículo científico publicado en 2012

Myc protein overexpression is a feature of progression and adverse prognosis in multiple myeloma

scholarly article by Hanne E. H. Møller et al published 28 September 2018 in European Journal of Haematology

Myeloid neoplasm with prominent eosinophilia and PDGFRA rearrangement treated with imatinib mesylate

artículo científico publicado en 2010

NF-κB p50 activation associated with immune dysregulation confers poorer survival for diffuse large B-cell lymphoma patients with wild-type p53.

artículo científico publicado en 2017

NPM1 mutation is a stable marker for minimal residual disease monitoring in acute myeloid leukaemia patients with increased sensitivity compared to WT1 expression.

artículo científico publicado en 2011

Non-Hodgkin's lymphoma of the spermatic cord

artículo científico publicado en 1994

Occurrence and prognostic relevance of CD30 expression in post-transplant lymphoproliferative disorders.

artículo científico publicado en 2015

Omalizumab prevents anaphylaxis and improves symptoms in systemic mastocytosis: Efficacy and safety observations.

artículo científico publicado en 2017

Oncoprotein MDM2 overexpression is associated with poor prognosis in distinct non-Hodgkin's lymphoma entities

scientific article published on 01 November 1999

Outcome determinants for transformed indolent lymphomas treated with or without autologous stem-cell transplantation.

artículo científico publicado en 2014

P27 in cell cycle control and cancer.

artículo científico publicado en 2000

PD-1/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration: a study from the International DLBCL Consortium Prog

artículo científico publicado en 2019

Paclitaxel-Eluting Biodegradable Synthetic Vascular Prostheses: A Step Towards Reduction of Neointima Formation?

artículo científico publicado en 2009

Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study

artículo científico publicado en 2012

Patterns of anaphylaxis after diagnostic workup: A follow-up study of 226 patients with suspected anaphylaxis

artículo científico publicado en 2017

Pediatric Expression of Mast Cell Activation Disorders

artículo científico publicado en 2018

Post-transplant lymphoproliferative disorder following kidney transplantation: a population-based cohort study

artículo científico publicado en 2016

Predictive value of galectin-1 in the development and progression of HIV-associated lymphoma

artículo científico publicado en 2017

Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.

artículo científico publicado en 2014

Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries

artículo científico publicado en 2014

Primary thymic extranodal marginal zone B cell lymphoma as an incidental finding in a Caucasian woman

artículo científico publicado en 2015

Profiling of diffuse large B-cell lymphoma by immunohistochemistry: identification of prognostic subgroups.

artículo científico publicado en 2007

Prognosis of localized diffuse large B-cell lymphoma in younger patients

artículo científico publicado en 2003

Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy

artículo científico publicado en 2015

Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma

artículo científico publicado en 2015

Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma.

artículo científico publicado en 2015

Prognostic significance of metallothionein in B-cell lymphomas

artículo científico publicado en 2006

Prospective evaluation of the diagnostic value of sensitive KIT D816V mutation analysis of blood in adults with suspected systemic mastocytosis

artículo científico publicado en 2017

Proteasome inhibitors and IMiDs can overcome some high-risk cytogenetics in multiple myeloma but not gain 1q21.

artículo científico publicado en 2015

Proteomic analysis identifies galectin-1 as a predictive biomarker for relapsed/refractory disease in classical Hodgkin lymphoma

article

Proteomic profiling identifies outcome-predictive markers in patients with peripheral T-cell lymphoma, not otherwise specified

artículo científico publicado en 2018

Quantitative assessment of the JAK2 V617F allele burden: equivalent levels in peripheral blood and bone marrow

scientific article published on 12 July 2007

Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.

artículo científico publicado en 2013

Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients.

artículo científico publicado en 2013

Recognizing mastocytosis in patients with anaphylaxis: value of KIT D816V mutation analysis of peripheral blood.

artículo científico publicado en 2014

RelA NF-κB subunit activation as a therapeutic target in diffuse large B-cell lymphoma.

artículo científico publicado en 2016

Relapse of myeloid neoplasm with eosinophilia and PDGFRA rearrangement after imatinib discontinuation in a pediatric patient.

artículo científico publicado en 2014

Relationship of intratumoural protein expression patterns to age and Epstein-Barr virus status in classical Hodgkin lymphoma

artículo científico publicado en 2014

Risk of solid cancer, cardiovascular disease, anaphylaxis, osteoporosis and fractures in patients with systemic mastocytosis: A nationwide population-based study

artículo científico publicado en 2016

Sensitive KIT D816V mutation analysis of blood as a diagnostic test in mastocytosis

artículo científico publicado en 2014

Serum tryptase correlates with the KIT D816V mutation burden in adults with indolent systemic mastocytosis

artículo científico publicado en 2013

Single nucleotide variation in the TP53 3' untranslated region in diffuse large B-cell lymphoma treated with rituximab-CHOP: a report from the International DLBCL Rituximab-CHOP Consortium Program

artículo científico publicado en 2013

Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study.

artículo científico publicado en 2008

Successful management of transfusion-dependent congenital dyserythropoietic anemia type 1b with interferon alfa-2a

artículo científico publicado en 2017

Sustained major molecular response on interferon alpha-2b in two patients with polycythemia vera.

artículo científico publicado en 2008

Systemic mastocytosis is uncommon in KIT D816V mutation positive core-binding factor acute myeloid leukemia.

artículo científico publicado en 2012

TRPM4 expression is associated with activated B cell subtype and poor survival in diffuse large B cell lymphoma

artículo científico publicado en 2017

Targeted ultradeep next-generation sequencing as a method for KIT D816V mutation analysis in mastocytosis.

artículo científico publicado en 2015

Testicular lymphoma: a population-based study of incidence, clinicopathological correlations and prognosis. The Danish Lymphoma Study Group, LYFO.

artículo científico publicado en 1994

The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis--impact on disease phenotype

artículo científico publicado en 2007

Towards rational diagnostics in mastocytosis: clinical validation of sensitive KIT D816V mutation analysis of unfractionated whole-blood

scientific article published on 09 May 2018

Validation of putative reference genes for normalization of Q-RT-PCR data from paraffin-embedded lymphoid tissue

artículo científico publicado en 2009

Venom anaphylaxis can mimic other serious conditions and disclose important underlying disease

artículo científico publicado en 2018

[Hip pain as a paraneoplastic rheumatic syndrome in a patient with double-hit lymphoma] ⬇️

artículo científico publicado en 2014

[Mastocytosis]. ⬇️

artículo científico publicado en 2016

[New molecular markers within the chronic myeloproliferative disorders. I: the PRV-1 gene]

scientific article published on 01 September 2006

[New molecular markers within the chronic myeloproliferative disorders. II: the JAK2 mutation]

scientific article published on 01 September 2006

p63 expression confers significantly better survival outcomes in high-risk diffuse large B-cell lymphoma and demonstrates p53-like and p53-independent tumor suppressor function

artículo científico publicado en 2016

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda